Søgeresultater - Curti, Brendan D
- Showing 1 - 19 results of 19
-
1
-
2
Development and Characterization of Recombinant Human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain af Morris, Nicholas P., Peters, Carmen, Montler, Ryan, Hu, Hong-Ming, Curti, Brendan D., Urba, Walter J., Weinberg, Andrew D.
Udgivet 2007Text -
3
Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program af Payne, Roxanne, Glenn, Lyn, Hoen, Helena, Richards, Beverley, Smith, John W, Lufkin, Robert, Crocenzi, Todd S, Urba, Walter J, Curti, Brendan D
Udgivet 2014Text -
4
Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance af Couey, Marcus A., Bell, R. Bryan, Patel, Ashish A., Romba, Meghan C., Crittenden, Marka R., Curti, Brendan D., Urba, Walter J., Leidner, Rom S.
Udgivet 2019Text -
5
Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab af Koguchi, Yoshinobu, Iwamoto, Noriko, Shimada, Takashi, Chang, Shu-Ching, Cha, John, Curti, Brendan D, Urba, Walter J, Piening, Brian D, Redmond, William L
Udgivet 2021Text -
6
Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer af van de Ven, Rieneke, Hilton, Traci L., Hu, Hong-Ming, Dubay, Christopher J., Haley, Daniel, Paustian, Christopher, Puri, Sachin, Urba, Walter J., Curti, Brendan D., Aung, Sandra, Fox, Bernard A.
Udgivet 2018Text -
7
Novel strategy to monitor apparent tumor-specific T cells in patients with cancer af van de Ven, Rieneke, Hilton, Traci L, Dubay, Christopher J, Puri, Sachin, Hu, Hong-Ming, Leidner, Rom S, Bell, R Bryan, Urba, Walter J, Curti, Brendan D, Aung, Sandra, Fox, Bernard A
Udgivet 2013Text -
8
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells af Duhen, Rebekka, Ballesteros-Merino, Carmen, Frye, Alexandra K., Tran, Eric, Rajamanickam, Venkatesh, Chang, Shu-Ching, Koguchi, Yoshinobu, Bifulco, Carlo B., Bernard, Brady, Leidner, Rom S., Curti, Brendan D., Fox, Bernard A., Urba, Walter J., Bell, R. Bryan, Weinberg, Andrew D.
Udgivet 2021Text -
9
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition af Buchbinder, Elizabeth I., Dutcher, Janice P., Daniels, Gregory A., Curti, Brendan D., Patel, Sapna P., Holtan, Shernan G., Miletello, Gerald P., Fishman, Mayer N., Gonzalez, Rene, Clark, Joseph I., Richart, John M., Lao, Christopher D., Tykodi, Scott S., Silk, Ann W., McDermott, David F.
Udgivet 2019Text -
10
Out-of-sequence Signal 3 paralyzes primary CD4(+) T cell dependent immunity af Sckisel, Gail D., Bouchlaka, Myriam N., Monjazeb, Arta M., Crittenden, Marka, Curti, Brendan D., Wilkins, Danice E.C., Alderson, Kory A., Sungur, Can M., Ames, Erik, Mirsoian, Annie, Reddy, Abhinav, Alexander, Warren, Soulika, Athena, Blazar, Bruce R., Longo, Dan L., Wiltrout, Robert H., Murphy, William J.
Udgivet 2015Text -
11
HDAC inhibition prevents transgene expression downregulation and loss-of-function in T-cell-receptor-transduced T cells af Moore, Tamson V., Scurti, Gina M., DeJong, Matthew, Wang, Siao-Yi, Dalheim, Annika V., Wagner, Courtney R., Hutchens, Kelli A., Speiser, Jodi J., Godellas, Constantine V., Fountain, Chris, Fleser, Jessica, Moudgil, Tarsem, Thomas, Mallory, Murray, David, Curti, Brendan D., Clark, Joseph I., Fox, Bernard A., Nishimura, Michael I.
Udgivet 2021Text -
12
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor af Curti, Brendan D, Koguchi, Yoshinobu, Leidner, Rom S, Rolig, Annah S, Sturgill, Elizabeth R, Sun, Zhaoyu, Wu, Yaping, Rajamanickam, Venkatesh, Bernard, Brady, Hilgart-Martiszus, Ian, Fountain, Christopher B, Morris, George, Iwamoto, Noriko, Shimada, Takashi, Chang, ShuChing, Traber, Peter G, Zomer, Eliezer, Horton, J Rex, Shlevin, Harold, Redmond, William L
Udgivet 2021Text -
13
Signaling through OX40 Enhances Anti-tumor Immunity af Jensen, Shawn M., Maston, Levi D., Gough, Michael J., Ruby, Carl E., Redmond, William L., Crittenden, Marka, Li, Yuhuan, Puri, Sachin, Poehlein, Christian H., Morris, Nick, Kovacsovics-Bankowski, Magdalena, Moudgil, Tarsem, Twitty, Chris, Walker, Edwin B., Hu, Hong-Ming, Urba, Walter J., Weinberg, Andrew D., Curti, Brendan D, Fox, Bernard A.
Udgivet 2010Text -
14
Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma af Diab, Adi, Tykodi, Scott S., Daniels, Gregory A., Maio, Michele, Curti, Brendan D., Lewis, Karl D., Jang, Sekwon, Kalinka, Ewa, Puzanov, Igor, Spira, Alexander I., Cho, Daniel C., Guan, Shanhong, Puente, Erika, Nguyen, Tuan, Hoch, Ute, Currie, Sue L., Lin, Wei, Tagliaferri, Mary A., Zalevsky, Jonathan, Sznol, Mario, Hurwitz, Michael E.
Udgivet 2021Text -
15
OX40 is a potent immune stimulating target in late stage cancer patients af Curti, Brendan D., Kovacsovics-Bankowski, Magdalena, Morris, Nicholas, Walker, Edwin, Chisholm, Lana, Floyd, Kevin, Walker, Joshua, Gonzalez, Iliana, Meeuwsen, Tanisha, Fox, Bernard A., Moudgil, Tarsem, Miller, William, Haley, Daniel, Coffey, Todd, Fisher, Brenda, Delanty-Miller, Laurie, Rymarchyk, Nicole, Kelly, Tracy, Crocenzi, Todd, Bernstein, Eric, Sanborn, Rachel, Urba, Walter J., Weinberg, Andrew D.
Udgivet 2013Text -
16
A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma af Buchbinder, Elizabeth I., Gunturi, Anasuya, Perritt, Jessica, Dutcher, Janice, Aung, Sandra, Kaufman, Howard L., Ernstoff, Marc S., Miletello, Girald P., Curti, Brendan D., Daniels, Gregory A., Patel, Sapna P., Kirkwood, John M., Hallmeyer, Sigrun, Clark, Joseph I., Gonzalez, Rene, Richart, John M., Lutzky, Joe, Morse, Michael A., Sullivan, Ryan J., McDermott, David F.
Udgivet 2016Text -
17
Cancer Immunotherapy: The Role Regulatory T cells Play and What can be Done to Overcome their Inhibitory Effects af Petrausch, Ulf, Poehlein, Christian H., Jensen, Shawn M., Twitty, Chris, Thompson, James A., Assmann, Ilka, Puri, Sachin, LaCelle, Michael G., Moudgil, Tarsem, Maston, Levi, Friedman, Kevin, Church, Sarah, Cardenas, Elisa, Haley, Daniel P., Walker, Edwin B., Akporiaye, Emmanuel, Weinberg, Andrew D., Rosenheim, Sidney, Crocenzi, Todd S., Hu, Hong-Ming, Curti, Brendan D., Urba, Walter J., Fox, Bernard A.
Udgivet 2009Text -
18
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma af Sarnaik, Amod A., Hamid, Omid, Khushalani, Nikhil I., Lewis, Karl D., Medina, Theresa, Kluger, Harriet M., Thomas, Sajeve S., Domingo-Musibay, Evidio, Pavlick, Anna C., Whitman, Eric D., Martin-Algarra, Salvador, Corrie, Pippa, Curti, Brendan D., Oláh, Judit, Lutzky, Jose, Weber, Jeffrey S., Larkin, James M. G., Shi, Wen, Takamura, Toshimi, Jagasia, Madan, Qin, Harry, Wu, Xiao, Chartier, Cecile, Graf Finckenstein, Friedrich, Fardis, Maria, Kirkwood, John M., Chesney, Jason A.
Udgivet 2021Text -
19
The High-Dose Aldesleukin “Select” Trial: A Trial to Prospectively Validate Predictive Models of Response Treatment in Patients with Metastatic Renal Cell Carcinoma af McDermott, David F., Cheng, Su-Chun, Signoretti, Sabina, Margolin, Kim A., Clark, Joseph I., Sosman, Jeffrey A., Dutcher, Janice P., Logan, Theodore F., Curti, Brendan D., Ernstoff, Marc S., Appleman, Leonard, Wong, Michael K.K., Khushalani, Nikhil I., Oleksowicz, Leslie, Vaishampayan, Ulka N., Mier, James W., Panka, David J., Bhatt, Rupal S., Bailey, Alexandra S., Leibovich, Bradley C., Kwon, Eugene D., Kabbinavar, Fairooz F., Belldegrun, Arie S., Figlin, Robert A., Pantuck, Allan J., Regan, Meredith M., Atkins, Michael B.
Udgivet 2014Text